Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
EISAI
Seed–Growth
Entrepreneurs Fund
LondonSeries A–Growth
EQT Fund Management S.à.r.l.
Seed–Growth
Future Fund: Breakthrough
Series B–Growth
Hong Kong X Technology Fund
Hong KongSeed–Growth
HSBC Innovation Ventures
LondonSeed–Growth
Hunt BioVentures
DallasSeed–Growth
Innovate Calgary
CalgaryPre-Seed–Growth
Investissement Quebec
Quebec CitySeed–Growth
IP Group
LondonSeed–Late Stage
Lake Bleu Capital
Hong KongSeed–Growth
Northern Gritstone
ManchesterSeed–Growth
Providence Investment Company Limited
GermanySeed–Growth
Quark Venture Inc.
VancouverSeed–Series C
RecapHealth Ventures
VancouverSeed–Late Stage
Roadmap Capital Inc.
TorontoSeed–Late Stage
SDIC Venture Capital / SDIC Fund Management
BeijingSeed–Growth
Treefrog Accelerator
Greater Toronto AreaSeed–Growth
Venture Labo Investment
TokyoSeed–Late Stage
Woodford Investment Management
OxfordSeries A–Growth
XGen Venture SGR
Seed–Growth
Yamauchi No.10 Family Office
TokyoSeed–Growth
Zero2IPO
BeijingSeed–Late Stage
Zhangjiang Hi-Tech incubation ecosystem
ShanghaiPre-Seed–Growth
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (946)Biotech Series B Investors & VC Firms (900)Series C Investors & VC Firms in Global (896)Biotech Pre-Seed Investors & VC Firms (896)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.